Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Mar 2, 2026 (7 months ago)

Children's Ibuprofen Oral Suspension

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8.

Affected NDC 51672-5321-08

Compare with the code on your package — it is the most precise check available.

Drug: Ibuprofen Category: Pain Relief & OTC Medication

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
ibuprofen
NDC 51672-5321
100 mg/5mL Suspension
Oral
Sun Pharmaceutical Industries, Inc. OTC
Recalling firm
Strides Pharma INC
NDC code
51672-5321-8
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0390-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Ibuprofen recalls

See all
Class II · Moderate risk

Advil a) Ibuprofen

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0261-2026
Class III · Low risk

IBU (ibuprofen)

Failed Tablet/Capsule Specifications

Ongoing Failed specification Dr. Reddy's Laboratories, Inc. NDC 55111-683-05 D-0047-2025
Class II · Moderate risk

Ibuprofen 800mg

Failed Impurities/Degradation Specifications: Product failed impurity specifications at the 18-month stability testing.

Ongoing Impurity / degradation Direct Rx NDC 61919-0621-15 D-0041-2025
Class II · Moderate risk

Ibuprofen Tablets

Failed Impurities/Degradation Specifications - at 18-month Stability testing

Ongoing Impurity / degradation Preferred Pharmaceuticals, Inc. NDC 68788-9110-03 D-0647-2024

Other recalls by Strides Pharma INC

All 2026 recalls